<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>315001</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>1280333</PubmedId>
            <Abstract>The protective association between the human leukocyte antigen HLA-B53 and severe malaria was investigated by sequencing of peptides eluted from this molecule followed by screening of candidate epitopes from pre-erythrocytic-stage antigens of Plasmodium falciparum in biochemical and cellular assays. Among malaria-immune Africans, HLA-B53-restricted cytotoxic T lymphocytes recognized a conserved nonamer peptide from liver-stage-specific antigen-1 (LSA-1), but no HLA-B53-restricted epitopes were identified in other antigens. These findings indicate a possible molecular basis for this HLA-disease association and support the candidacy of liver-stage-specific antigen-1 as a malaria vaccine component.</Abstract>
            <ArticleYear>1992</ArticleYear>
            <ArticlePages>434-9</ArticlePages>
            <ArticleTitle>Molecular analysis of the association of HLA-B53 and resistance to severe malaria.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Hill</LastName>
                    <ForeName>A V</ForeName>
                </Author>
                <Author>
                    <LastName>Elvin</LastName>
                    <ForeName>J</ForeName>
                </Author>
                <Author>
                    <LastName>Willis</LastName>
                    <ForeName>A C</ForeName>
                </Author>
                <Author>
                    <LastName>Aidoo</LastName>
                    <ForeName>M</ForeName>
                </Author>
                <Author>
                    <LastName>Allsopp</LastName>
                    <ForeName>C E</ForeName>
                </Author>
                <Author>
                    <LastName>Gotch</LastName>
                    <ForeName>F M</ForeName>
                </Author>
                <Author>
                    <LastName>Gao</LastName>
                    <ForeName>X M</ForeName>
                </Author>
                <Author>
                    <LastName>Takiguchi</LastName>
                    <ForeName>M</ForeName>
                </Author>
                <Author>
                    <LastName>Greenwood</LastName>
                    <ForeName>B M</ForeName>
                </Author>
                <Author>
                    <LastName>Townsend</LastName>
                    <ForeName>A R</ForeName>
                </Author>
            </Authors>
            <Affiliations>Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, UK.</Affiliations>
            <ArticleChemicalList>Antigens, Protozoan;Epitopes;HLA Antigens;HLA-B53 antigen;Oligodeoxyribonucleotides;Vaccines;liver stage-specific antigen, Plasmodium</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Antigens, Protozoan(genetics; immunology); B-Lymphocytes(immunology); Base Sequence; Cell Line; Epitopes(analysis; immunology); Genetic Variation; HLA Antigens(genetics; immunology; isolation &amp; purification); Histocompatibility Testing; Humans; Immunity, Innate; Liver(immunology; parasitology); Malaria(immunology); Malaria, Falciparum(immunology); Molecular Sequence Data; Oligodeoxyribonucleotides; Plasmodium falciparum(immunology); Polymerase Chain Reaction; T-Lymphocytes, Cytotoxic(immunology); Vaccines</ArticleMeshHeadingsList>
            <Comments>Data originally imported from the Database of Functional Molecular Immunology, FIMM (http://sdmc.lit.org.sg:8080/fimm/) and from the HLA Ligand Database (http://hlaligand.ouhsc.edu/)</Comments>
            <Journal>
                <Volume>360</Volume>
                <Issue>6403</Issue>
                <Title>Nature</Title>
                <Issn>1476-4687</Issn>
                <MedlineTa>Nature</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KPKDELDY</LinearSequence>
                        <StartingPosition>368</StartingPosition>
                        <EndingPosition>375</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P02893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>32741</EpitopeId>
                <ReferenceStartingPosition>368</ReferenceStartingPosition>
                <ReferenceEndingPosition>375</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The following refers to the epitope id as found in the original FIMM database: P000466.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>1345344</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <GeoLocId>http://purl.obolibrary.org/obo/GAZ_00000907</GeoLocId>
                                <Age>Adults</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Plasmodium falciparum [Mosquito Stage] [sporozoite]</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KPKDELDY</LinearSequence>
                                            <StartingPosition>368</StartingPosition>
                                            <EndingPosition>375</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P02893.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Donors were from the Gambian village, Brefet, which has hyperendemic malaria. PBMC were collected at the time of year with lowest malaria transmission.  PBMC were stimulated with a pool of peptides, each containing the HLA-B*3501-binding motif, and including the epitope and cp27, cp28, and cp29. IL-2 was added at 72 h. CTL assays were performed on day 8.  Epitope-specific CTL lines were maintained by weekly restimulation with irradiated autologous epitope-pulsed BCL.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>195</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>cp26</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KPKDELDY</LinearSequence>
                                        <StartingPosition>368</StartingPosition>
                                        <EndingPosition>375</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P02893.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>8</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>12.5</ResponseFrequency>
                            <AssayComments>CTL derived from 1 of 8 donors from a malaria-hyperendemic area of Gambia were stimulated by the epitope. CTL did not recognize two other naturally occurring variants of the epitope, cp28 (KPKDQLNY) and cp29 (KSKDELDY), and showed limited recognition of another variant, cp27 (KPKDQLDY).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KSKDELDY</LinearSequence>
                        <StartingPosition>392</StartingPosition>
                        <EndingPosition>399</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>Q27325</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>33362</EpitopeId>
                <ReferenceStartingPosition>392</ReferenceStartingPosition>
                <ReferenceEndingPosition>399</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The following refers to the epitope id as found in the original FIMM database: P000467.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>1345347</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <GeoLocId>http://purl.obolibrary.org/obo/GAZ_00000907</GeoLocId>
                                <Age>Adults</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Plasmodium falciparum [Mosquito Stage] [sporozoite]</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KSKDELDY</LinearSequence>
                                            <StartingPosition>392</StartingPosition>
                                            <EndingPosition>399</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>Q27325</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Donors were from the Gambian village, Brefet, which has hyperendemic malaria. PBMC were collected at the time of year with lowest malaria transmission.  PBMC were stimulated with a pool of peptides each containing the HLA-B*3501-binding motif, and including the epitope and cp26,cp27, and cp28. IL-2 was added at 72 h. CTL assays were performed on day 8.  Epitope-specific CTL lines were maintained by weekly restimulation with irradiated autologous epitope-pulsed BCL.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>195</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>cp29</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KSKDELDY</LinearSequence>
                                        <StartingPosition>392</StartingPosition>
                                        <EndingPosition>399</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q27325</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>8</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>12.5</ResponseFrequency>
                            <AssayComments>CTL derived from 1 of 8 donors from a malaria-hyperendemic area of Gambia were stimulated by the epitope. CTL lysis was blocked by anti-CD8 antibodies. The CTL did not recognize three other naturally occurring variants of the epitope, cp26 (KPKDELDY), cp27 (KPKDQLDY), or cp28 (KPKDQLNY).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KPNDKSLY</LinearSequence>
                        <StartingPosition>1850</StartingPosition>
                        <EndingPosition>1857</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>Q25893</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>32802</EpitopeId>
                <ReferenceStartingPosition>1850</ReferenceStartingPosition>
                <ReferenceEndingPosition>1857</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The following refers to the epitope id as found in the original FIMM database: P000468.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>1345348</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <GeoLocId>http://purl.obolibrary.org/obo/GAZ_00000907</GeoLocId>
                                <Age>Adults</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Plasmodium falciparum [Mosquito Stage] [sporozoite]</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KPNDKSLY</LinearSequence>
                                            <StartingPosition>1850</StartingPosition>
                                            <EndingPosition>1857</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>Q25893</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Donors were from the Gambian village, Brefet, which has hyperendemic malaria. PBMC were collected at the time of year with lowest malaria transmission.  PBMC were stimulated with a pool of peptides, each containing the HLA-B*3501-binding motif, and including the epitope. IL-2 was added at 72 h. CTL assays were performed on day 8.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>195</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>ls8</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KPNDKSLY</LinearSequence>
                                        <StartingPosition>1850</StartingPosition>
                                        <EndingPosition>1857</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q25893</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>8</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>1</NumberOfSubjectsResponded>
                            <ResponseFrequency>12.5</ResponseFrequency>
                            <AssayComments>CTL derived from 1 of 8 donors from a malaria-hyperendemic area of Gambia were stimulated by the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KPIVQYDNF</LinearSequence>
                        <StartingPosition>1786</StartingPosition>
                        <EndingPosition>1794</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>Q25893</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <EpitopeId>32738</EpitopeId>
                <ReferenceStartingPosition>1786</ReferenceStartingPosition>
                <ReferenceEndingPosition>1794</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The following refers to the epitope id as found in the original FIMM database: P000552.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>1342126</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <GeoLocId>http://purl.obolibrary.org/obo/GAZ_00000907</GeoLocId>
                                <Age>Adults</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Plasmodium falciparum [Mosquito Stage] [sporozoite]</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KPIVQYDNF</LinearSequence>
                                            <StartingPosition>1786</StartingPosition>
                                            <EndingPosition>1794</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>Q25893</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Donors were from the Gambian village, Brefet, which has hyperendemic malaria. PBMC were collected at the time of year with lowest malaria transmission.  PBMC were stimulated with a pool of HLA-B*5301-binding peptides, including the epitope, and IL-2 was added at 72 h. CTL assays were performed on day 8.  Epitope-specific CTL lines were maintained by weekly restimulation with irradiated autologous epitope-pulsed BCL.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>44</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>ls6</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KPIVQYDNF</LinearSequence>
                                        <StartingPosition>1786</StartingPosition>
                                        <EndingPosition>1794</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q25893</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>3</NumberOfSubjectsResponded>
                            <ResponseFrequency>50</ResponseFrequency>
                            <AssayComments>CTL derived from 3 of 6 donors from a malaria-hyperendemic area of Gambia were stimulated by the epitope. CTL lysis was inhibitable by anti-CD8 antibodies. The response was genetically restricted as demonstarted by the inability of CTL to lyse HLA-B*5301-mismatched target cells pulsed with the epitope. DNA sequencing of 9 Gambian isolates of the malaria parasite showed that the epitope sequence is conserved.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1 and Table 2</LocationOfData>
                        <MhcBindingId>1342124</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing. The truncated peptide, ls9 (KPIVQYDN), also did not bind.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1 and Table 2</LocationOfData>
                        <MhcBindingId>1342125</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope was shown to bind HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing. The truncated peptide, ls9 (KPIVQYDN), did not bind.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp6</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MPNDPNRNV</LinearSequence>
                        <StartingPosition>300</StartingPosition>
                        <EndingPosition>308</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P02893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>42295</EpitopeId>
                <ReferenceStartingPosition>300</ReferenceStartingPosition>
                <ReferenceEndingPosition>308</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>1342104</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <GeoLocId>http://purl.obolibrary.org/obo/GAZ_00000907</GeoLocId>
                                <Age>Adults</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Plasmodium falciparum [Mosquito Stage] [sporozoite]</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MPNDPNRNV</LinearSequence>
                                            <StartingPosition>300</StartingPosition>
                                            <EndingPosition>308</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P02893.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Donors were from the Gambian village, Brefet, which has hyperendemic malaria. PBMC were collected at the time of year with lowest malaria transmission.  PBMC were stimulated with a pool of HLA-B*5301-binding peptides, including the epitope, and IL-2 was added at 72 h. CTL assays were performed on day 8.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>44</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>cp6</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MPNDPNRNV</LinearSequence>
                                        <StartingPosition>300</StartingPosition>
                                        <EndingPosition>308</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P02893.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTL derived from donors from a malaria-hyperendemic area of Gambia were not stimulated by the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>1342103</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope was shown to bind HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1 and Table 2</LocationOfData>
                        <MhcBindingId>1342102</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope was shown to bind HLA-B*5301 (HLA-B53) weakly as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp6.1</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MPNYPNRNV</LinearSequence>
                        <SourceMolecule>
                            <IedbAccession>SRC280011</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>42307</EpitopeId>
                <ReferenceStartingPosition>300</ReferenceStartingPosition>
                <ReferenceEndingPosition>308</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Internal Identifier-no external match available</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The sequence is from an allelic variant of the circumsporozoite protein.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>1342106</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <GeoLocId>http://purl.obolibrary.org/obo/GAZ_00000907</GeoLocId>
                                <Age>Adults</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Plasmodium falciparum [Mosquito Stage] [sporozoite]</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MPNYPNRNV</LinearSequence>
                                            <SourceMolecule>
                                                <IedbAccession>SRC280011</IedbAccession>
                                            </SourceMolecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Donors were from the Gambian village, Brefet, which has hyperendemic malaria. PBMC were collected at the time of year with lowest malaria transmission.  PBMC were stimulated with a pool of HLA-B*5301-binding peptides, including the epitope, and IL-2 was added at 72 h. CTL assays were performed on day 8.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>44</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>cp6.1</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MPNYPNRNV</LinearSequence>
                                        <SourceMolecule>
                                            <IedbAccession>SRC280011</IedbAccession>
                                        </SourceMolecule>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTL derived from donors from a malaria-hyperendemic area of Gambia were not stimulated by the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>1342105</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope bound poorly to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1 and Table 2</LocationOfData>
                        <MhcBindingId>1342107</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope was shown to bind HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp6.2</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MPNNPNRNV</LinearSequence>
                        <StartingPosition>5</StartingPosition>
                        <EndingPosition>13</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA29519.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>42303</EpitopeId>
                <ReferenceStartingPosition>300</ReferenceStartingPosition>
                <ReferenceEndingPosition>308</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The sequence is from an allelic variant of the circumsporozoite protein.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>1342108</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <GeoLocId>http://purl.obolibrary.org/obo/GAZ_00000907</GeoLocId>
                                <Age>Adults</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Plasmodium falciparum [Mosquito Stage] [sporozoite]</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MPNNPNRNV</LinearSequence>
                                            <StartingPosition>5</StartingPosition>
                                            <EndingPosition>13</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29519.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Donors were from the Gambian village, Brefet, which has hyperendemic malaria. PBMC were collected at the time of year with lowest malaria transmission.  PBMC were stimulated with a pool of HLA-B*5301-binding peptides, including the epitope, and IL-2 was added at 72 h. CTL assays were performed on day 8.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>44</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>cp6.2</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MPNNPNRNV</LinearSequence>
                                        <StartingPosition>5</StartingPosition>
                                        <EndingPosition>13</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA29519.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTL derived from donors from a malaria-hyperendemic area of Gambia were not stimulated by the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>1342110</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope bound poorly to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>290</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1 and Table 2</LocationOfData>
                        <MhcBindingId>1342109</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope was shown to bind HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>sh6</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MPLETQLAI</LinearSequence>
                        <StartingPosition>77</StartingPosition>
                        <EndingPosition>85</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA29733.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>42290</EpitopeId>
                <ReferenceStartingPosition>77</ReferenceStartingPosition>
                <ReferenceEndingPosition>85</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The sequence is from the sporozoite hepatocyte-binding antigen (SHEBA or Pfs16) expressed on sporozoites and gametocytes.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>1342113</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <GeoLocId>http://purl.obolibrary.org/obo/GAZ_00000907</GeoLocId>
                                <Age>Adults</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Plasmodium falciparum [Mosquito Stage] [sporozoite]</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>MPLETQLAI</LinearSequence>
                                            <StartingPosition>77</StartingPosition>
                                            <EndingPosition>85</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29733.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Donors were from the Gambian village, Brefet, which has hyperendemic malaria. PBMC were collected at the time of year with lowest malaria transmission.  PBMC were stimulated with a pool of HLA-B*5301-binding peptides, including the epitope, and IL-2 was added at 72 h. CTL assays were performed on day 8.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>44</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>sh6</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MPLETQLAI</LinearSequence>
                                        <StartingPosition>77</StartingPosition>
                                        <EndingPosition>85</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA29733.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTL derived from donors from a malaria-hyperendemic area of Gambia were not stimulated by the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1 and Table 2</LocationOfData>
                        <MhcBindingId>1342111</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope was shown to bind HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>1342112</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope was shown to bind HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with anti-monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>sh1</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IPSLALMLI</LinearSequence>
                        <StartingPosition>7</StartingPosition>
                        <EndingPosition>15</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA29733.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>28064</EpitopeId>
                <ReferenceStartingPosition>7</ReferenceStartingPosition>
                <ReferenceEndingPosition>159</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The sequence is from the sporozoite hepatocyte-binding antigen (SHEBA or Pfs16) expressed on sporozoites and gametocytes.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>1342114</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <GeoLocId>http://purl.obolibrary.org/obo/GAZ_00000907</GeoLocId>
                                <Age>Adults</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Plasmodium falciparum [Mosquito Stage] [sporozoite]</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>IPSLALMLI</LinearSequence>
                                            <StartingPosition>7</StartingPosition>
                                            <EndingPosition>15</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAA29733.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Donors were from the Gambian village, Brefet, which has hyperendemic malaria. PBMC were collected at the time of year with lowest malaria transmission.  PBMC were stimulated with a pool of HLA-B*5301-binding peptides, including the epitope, and IL-2 was added at 72 h. CTL assays were performed on day 8.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>44</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>sh1</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IPSLALMLI</LinearSequence>
                                        <StartingPosition>7</StartingPosition>
                                        <EndingPosition>15</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAA29733.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTL derived from donors from a malaria-hyperendemic area of Gambia were not stimulated by the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1</LocationOfData>
                        <MhcBindingId>1342115</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope was shown to bind HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1 and Table 2</LocationOfData>
                        <MhcBindingId>1342116</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope was shown to bind HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>tr15</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EPAPFDETL</LinearSequence>
                        <StartingPosition>529</StartingPosition>
                        <EndingPosition>537</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>13615</EpitopeId>
                <ReferenceStartingPosition>529</ReferenceStartingPosition>
                <ReferenceEndingPosition>537</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>1342118</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <GeoLocId>http://purl.obolibrary.org/obo/GAZ_00000907</GeoLocId>
                                <Age>Adults</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Plasmodium falciparum [Mosquito Stage] [sporozoite]</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EPAPFDETL</LinearSequence>
                                            <StartingPosition>529</StartingPosition>
                                            <EndingPosition>537</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P16893.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Donors were from the Gambian village, Brefet, which has hyperendemic malaria. PBMC were collected at the time of year with lowest malaria transmission.  PBMC were stimulated with a pool of HLA-B*5301-binding peptides, including the epitope, and IL-2 was added at 72 h. CTL assays were performed on day 8.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>44</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>tr15</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EPAPFDETL</LinearSequence>
                                        <StartingPosition>529</StartingPosition>
                                        <EndingPosition>537</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P16893.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTL derived from donors from a malaria-hyperendemic area of Gambia were not stimulated by the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345362</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1342119</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope was shown to bind HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>tr20</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>HPSDGKCNL</LinearSequence>
                        <StartingPosition>206</StartingPosition>
                        <EndingPosition>214</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>24501</EpitopeId>
                <ReferenceStartingPosition>206</ReferenceStartingPosition>
                <ReferenceEndingPosition>214</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>1342121</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <GeoLocId>http://purl.obolibrary.org/obo/GAZ_00000907</GeoLocId>
                                <Age>Adults</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Plasmodium falciparum [Mosquito Stage] [sporozoite]</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>HPSDGKCNL</LinearSequence>
                                            <StartingPosition>206</StartingPosition>
                                            <EndingPosition>214</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P16893.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Donors were from the Gambian village, Brefet, which has hyperendemic malaria. PBMC were collected at the time of year with lowest malaria transmission.  PBMC were stimulated with a pool of HLA-B*5301-binding peptides, including the epitope, and IL-2 was added at 72 h. CTL assays were performed on day 8.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>44</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>tr20</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>HPSDGKCNL</LinearSequence>
                                        <StartingPosition>206</StartingPosition>
                                        <EndingPosition>214</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P16893.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTL derived from donors from a malaria-hyperendemic area of Gambia were not stimulated by the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1342120</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope was shown to bind HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345363</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>tr16</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>VPDEPEDDQ</LinearSequence>
                        <StartingPosition>295</StartingPosition>
                        <EndingPosition>303</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>70265</EpitopeId>
                <ReferenceStartingPosition>295</ReferenceStartingPosition>
                <ReferenceEndingPosition>303</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 2</LocationOfData>
                        <TCellId>1342123</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <GeoLocId>http://purl.obolibrary.org/obo/GAZ_00000907</GeoLocId>
                                <Age>Adults</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Plasmodium falciparum [Mosquito Stage] [sporozoite]</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>VPDEPEDDQ</LinearSequence>
                                            <StartingPosition>295</StartingPosition>
                                            <EndingPosition>303</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P16893.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Donors were from the Gambian village, Brefet, which has hyperendemic malaria. PBMC were collected at the time of year with lowest malaria transmission.  PBMC were stimulated with a pool of HLA-B*5301-binding peptides, including the epitope, and IL-2 was added at 72 h. CTL assays were performed on day 8.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>44</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>tr16</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VPDEPEDDQ</LinearSequence>
                                        <StartingPosition>295</StartingPosition>
                                        <EndingPosition>303</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P16893.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTL derived from donors from a malaria-hyperendemic area of Gambia were not stimulated by the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345364</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1342122</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope does not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ls2</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LPSENERGY</LinearSequence>
                        <StartingPosition>1663</StartingPosition>
                        <EndingPosition>1671</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>Q25893</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>38704</EpitopeId>
                <ReferenceStartingPosition>1663</ReferenceStartingPosition>
                <ReferenceEndingPosition>1671</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>1345349</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <GeoLocId>http://purl.obolibrary.org/obo/GAZ_00000907</GeoLocId>
                                <Age>Adults</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Plasmodium falciparum [Mosquito Stage] [sporozoite]</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>LPSENERGY</LinearSequence>
                                            <StartingPosition>1663</StartingPosition>
                                            <EndingPosition>1671</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>Q25893</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Donors were from the Gambian village, Brefet, which has hyperendemic malaria. PBMC were collected at the time of year with lowest malaria transmission.  PBMC were stimulated with a pool of peptides, each containing the HLA-B*3501-binding motif, and including the epitope. IL-2 was added at 72 h. CTL assays were performed on day 8.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>195</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>ls2</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LPSENERGY</LinearSequence>
                                        <StartingPosition>1663</StartingPosition>
                                        <EndingPosition>1671</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>Q25893</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>8</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTL derived from 8 donors from a malaria-hyperendemic area of Gambia were not stimulated by the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345531</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345532</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp27</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KPKDQLDY</LinearSequence>
                        <StartingPosition>398</StartingPosition>
                        <EndingPosition>405</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P08307.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5848</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>32756</EpitopeId>
                <ReferenceStartingPosition>368</ReferenceStartingPosition>
                <ReferenceEndingPosition>375</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>1345350</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <GeoLocId>http://purl.obolibrary.org/obo/GAZ_00000907</GeoLocId>
                                <Age>Adults</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Taxonomic Parent</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Plasmodium falciparum [Mosquito Stage] [sporozoite]</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KPKDQLDY</LinearSequence>
                                            <StartingPosition>398</StartingPosition>
                                            <EndingPosition>405</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P08307.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5848</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Donors were from the Gambian village, Brefet, which has hyperendemic malaria. PBMC were collected at the time of year with lowest malaria transmission.  PBMC were stimulated with a pool of peptides, each containing the HLA-B*3501-binding motif, and including the epitope and cp26, cp28, and cp29. IL-2 was added at 72 h. CTL assays were performed on day 8.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>195</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>cp27</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KPKDQLDY</LinearSequence>
                                        <StartingPosition>398</StartingPosition>
                                        <EndingPosition>405</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P08307.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5848</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>8</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTL, from 1 of 8 donors from a malaria-hyperendemic area of Gambia, stimulated with the epitope showed 13.7% specific lysis, which was just below the level considered positive (15%). The CTL recognized the naturally occurring variant of the epitope, cp26 (KPKDELDY), but did not recognize two other variants, cp28 (KPKDQLNY) and cp29 (KSKDELDY).</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp28</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KPKDQLNY</LinearSequence>
                        <StartingPosition>330</StartingPosition>
                        <EndingPosition>337</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAW78213.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>32764</EpitopeId>
                <ReferenceStartingPosition>368</ReferenceStartingPosition>
                <ReferenceEndingPosition>375</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>1345351</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <GeoLocId>http://purl.obolibrary.org/obo/GAZ_00000907</GeoLocId>
                                <Age>Adults</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Plasmodium falciparum [Mosquito Stage] [sporozoite]</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>KPKDQLNY</LinearSequence>
                                            <StartingPosition>330</StartingPosition>
                                            <EndingPosition>337</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAW78213.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Donors were from the Gambian village, Brefet, which has hyperendemic malaria. PBMC were collected at the time of year with lowest malaria transmission.  PBMC were stimulated with a pool of peptides, each containing the HLA-B*3501-binding motif, and including the epitope. IL-2 was added at 72 h. CTL assays were performed on day 8.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>195</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>cp28</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>KPKDQLNY</LinearSequence>
                                        <StartingPosition>330</StartingPosition>
                                        <EndingPosition>337</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAW78213.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>8</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTL derived from 8 donors from a malaria-hyperendemic area of Gambia were not stimulated by the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp30</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EPSDKHIEQY</LinearSequence>
                        <StartingPosition>325</StartingPosition>
                        <EndingPosition>334</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P02893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>13752</EpitopeId>
                <ReferenceStartingPosition>325</ReferenceStartingPosition>
                <ReferenceEndingPosition>334</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>1345352</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <GeoLocId>http://purl.obolibrary.org/obo/GAZ_00000907</GeoLocId>
                                <Age>Adults</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Plasmodium falciparum [Mosquito Stage] [sporozoite]</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EPSDKHIEQY</LinearSequence>
                                            <StartingPosition>325</StartingPosition>
                                            <EndingPosition>334</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P02893.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Donors were from the Gambian village, Brefet, which has hyperendemic malaria. PBMC were collected at the time of year with lowest malaria transmission.  PBMC were stimulated with a pool of peptides, including the epitope, and each containing the HLA-B*3501-binding motif. IL-2 was added at 72 h. CTL assays were performed on day 8.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>195</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>cp30</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EPSDKHIEQY</LinearSequence>
                                        <StartingPosition>325</StartingPosition>
                                        <EndingPosition>334</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P02893.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>8</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTL derived from 8 donors from a malaria-hyperendemic area of Gambia were not stimulated by the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp31</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EPSDQHIEKY</LinearSequence>
                        <StartingPosition>287</StartingPosition>
                        <EndingPosition>296</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAW78194.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>13758</EpitopeId>
                <ReferenceStartingPosition>325</ReferenceStartingPosition>
                <ReferenceEndingPosition>334</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>1345353</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <GeoLocId>http://purl.obolibrary.org/obo/GAZ_00000907</GeoLocId>
                                <Age>Adults</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Plasmodium falciparum [Mosquito Stage] [sporozoite]</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EPSDQHIEKY</LinearSequence>
                                            <StartingPosition>287</StartingPosition>
                                            <EndingPosition>296</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>AAW78194.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Donors were from the Gambian village, Brefet, which has hyperendemic malaria. PBMC were collected at the time of year with lowest malaria transmission.  PBMC were stimulated with a pool of peptides, including the epitope, and each containing the HLA-B*3501-binding motif. IL-2 was added at 72 h. CTL assays were performed on day 8.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>195</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>cp31</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EPSDQHIEKY</LinearSequence>
                                        <StartingPosition>287</StartingPosition>
                                        <EndingPosition>296</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAW78194.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>8</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTL derived from 8 donors from a malaria-hyperendemic area of Gambia were not stimulated by the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>tr24</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>HPSDGKCNLY</LinearSequence>
                        <StartingPosition>206</StartingPosition>
                        <EndingPosition>215</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>24502</EpitopeId>
                <ReferenceStartingPosition>206</ReferenceStartingPosition>
                <ReferenceEndingPosition>215</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>1345354</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <GeoLocId>http://purl.obolibrary.org/obo/GAZ_00000907</GeoLocId>
                                <Age>Adults</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Plasmodium falciparum [Mosquito Stage] [sporozoite]</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>HPSDGKCNLY</LinearSequence>
                                            <StartingPosition>206</StartingPosition>
                                            <EndingPosition>215</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P16893.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Donors were from the Gambian village, Brefet, which has hyperendemic malaria. PBMC were collected at the time of year with lowest malaria transmission.  PBMC were stimulated with a pool of peptides, including the epitope, and each containing the HLA-B*3501-binding motif. IL-2 was added at 72 h. CTL assays were performed on day 8.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>195</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>tr24</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>HPSDGKCNLY</LinearSequence>
                                        <StartingPosition>206</StartingPosition>
                                        <EndingPosition>215</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P16893.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>8</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTL derived from 8 donors from a malaria-hyperendemic area of Gambia were not stimulated by the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>tr25</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>VPGAATPY</LinearSequence>
                        <StartingPosition>519</StartingPosition>
                        <EndingPosition>526</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>70297</EpitopeId>
                <ReferenceStartingPosition>519</ReferenceStartingPosition>
                <ReferenceEndingPosition>526</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>1345355</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <GeoLocId>http://purl.obolibrary.org/obo/GAZ_00000907</GeoLocId>
                                <Age>Adults</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Plasmodium falciparum [Mosquito Stage] [sporozoite]</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>VPGAATPY</LinearSequence>
                                            <StartingPosition>519</StartingPosition>
                                            <EndingPosition>526</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P16893.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Donors were from the Gambian village, Brefet, which has hyperendemic malaria. PBMC were collected at the time of year with lowest malaria transmission.  PBMC were stimulated with a pool of peptides, including the epitope, and each containing the HLA-B*3501-binding motif. IL-2 was added at 72 h. CTL assays were performed on day 8.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>195</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>tr25</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>VPGAATPY</LinearSequence>
                                        <StartingPosition>519</StartingPosition>
                                        <EndingPosition>526</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P16893.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>8</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTL derived from 8 donors from a malaria-hyperendemic area of Gambia were not stimulated by the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp2</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NPNANPNAN</LinearSequence>
                        <StartingPosition>150</StartingPosition>
                        <EndingPosition>158</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P02893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>45408</EpitopeId>
                <ReferenceStartingPosition>150</ReferenceStartingPosition>
                <ReferenceEndingPosition>158</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345357</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing. The octamer peptide cp1, NPNANPNA, also does not bind.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345358</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing. The octamer peptide cp1, NPNANPNA, also does not bind.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp3</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KPKHKKLKQ</LinearSequence>
                        <StartingPosition>107</StartingPosition>
                        <EndingPosition>115</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P02893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>32768</EpitopeId>
                <ReferenceStartingPosition>107</ReferenceStartingPosition>
                <ReferenceEndingPosition>115</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345359</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345360</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp4</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NPGDGNPDPG</LinearSequence>
                        <SourceMolecule>
                            <IedbAccession>SRC280011</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>45353</EpitopeId>
                <ReferenceStartingPosition>115</ReferenceStartingPosition>
                <EpitopeEvidenceCode>Internal Identifier-no external match available</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The peptide was made with a C-terminal Gly residue to aid synthesis.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345366</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345365</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp5</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NPDPNANPN</LinearSequence>
                        <StartingPosition>120</StartingPosition>
                        <EndingPosition>128</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P02893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>45323</EpitopeId>
                <ReferenceStartingPosition>120</ReferenceStartingPosition>
                <ReferenceEndingPosition>128</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345368</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345367</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp7</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>DPNRNVDGN</LinearSequence>
                        <SourceMolecule>
                            <IedbAccession>SRC280011</IedbAccession>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>9713</EpitopeId>
                <ReferenceStartingPosition>303</ReferenceStartingPosition>
                <EpitopeEvidenceCode>Internal Identifier-no external match available</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345370</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345369</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp8</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SPCSVTCGN</LinearSequence>
                        <StartingPosition>347</StartingPosition>
                        <EndingPosition>355</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P02893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>60007</EpitopeId>
                <ReferenceStartingPosition>347</ReferenceStartingPosition>
                <ReferenceEndingPosition>355</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345371</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345372</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp9</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KPGSANKPK</LinearSequence>
                        <StartingPosition>362</StartingPosition>
                        <EndingPosition>370</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P02893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>32729</EpitopeId>
                <ReferenceStartingPosition>362</ReferenceStartingPosition>
                <ReferenceEndingPosition>370</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345374</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345373</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp10</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KPKDELDYE</LinearSequence>
                        <StartingPosition>368</StartingPosition>
                        <EndingPosition>376</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P02893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>32747</EpitopeId>
                <ReferenceStartingPosition>368</ReferenceStartingPosition>
                <ReferenceEndingPosition>376</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345376</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345375</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp11</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EPSDKHIEQ</LinearSequence>
                        <StartingPosition>325</StartingPosition>
                        <EndingPosition>333</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P02893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>13751</EpitopeId>
                <ReferenceStartingPosition>325</ReferenceStartingPosition>
                <ReferenceEndingPosition>333</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345378</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345377</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp12</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EPSDQHIEK</LinearSequence>
                        <StartingPosition>310</StartingPosition>
                        <EndingPosition>318</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAN87583.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>13757</EpitopeId>
                <ReferenceStartingPosition>325</ReferenceStartingPosition>
                <ReferenceEndingPosition>333</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345497</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing. The octamer peptide, cp20 (EPSDQHIE), also did not bind.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345496</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing. The octamer peptide, cp20 (EPSDQHIE), also did not bind.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp13</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EPSDKHIKE</LinearSequence>
                        <StartingPosition>310</StartingPosition>
                        <EndingPosition>318</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P19597.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5843</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>13755</EpitopeId>
                <ReferenceStartingPosition>325</ReferenceStartingPosition>
                <ReferenceEndingPosition>333</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345499</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345498</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp14</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EPSDKHIEK</LinearSequence>
                        <StartingPosition>325</StartingPosition>
                        <EndingPosition>333</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAN87606.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>13750</EpitopeId>
                <ReferenceStartingPosition>325</ReferenceStartingPosition>
                <ReferenceEndingPosition>333</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345500</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345501</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp15</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KPGSADKPK</LinearSequence>
                        <StartingPosition>392</StartingPosition>
                        <EndingPosition>400</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P08307.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5848</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>32727</EpitopeId>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345502</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345503</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp16</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KPKDQLDYA</LinearSequence>
                        <StartingPosition>353</StartingPosition>
                        <EndingPosition>361</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAN87583.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>32757</EpitopeId>
                <ReferenceStartingPosition>368</ReferenceStartingPosition>
                <ReferenceEndingPosition>376</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345509</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345508</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp17</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KPKDELDYA</LinearSequence>
                        <StartingPosition>353</StartingPosition>
                        <EndingPosition>361</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P19597.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5843</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>32742</EpitopeId>
                <ReferenceStartingPosition>368</ReferenceStartingPosition>
                <ReferenceEndingPosition>376</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345511</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345510</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp18</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KPKDQLDYE</LinearSequence>
                        <StartingPosition>398</StartingPosition>
                        <EndingPosition>406</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P08307.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5848</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>32759</EpitopeId>
                <ReferenceStartingPosition>368</ReferenceStartingPosition>
                <ReferenceEndingPosition>376</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345513</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing. The octamer peptide, cp19 (KPKDQLDY), also did not bind.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345512</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing. The octamer peptide, cp19 (KPKDQLDY), also did not bind.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp21</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NPDPNANPNV</LinearSequence>
                        <StartingPosition>120</StartingPosition>
                        <EndingPosition>129</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P02893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>45324</EpitopeId>
                <ReferenceStartingPosition>120</ReferenceStartingPosition>
                <ReferenceEndingPosition>129</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345515</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345514</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp22</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NPNVDPNAN</LinearSequence>
                        <StartingPosition>126</StartingPosition>
                        <EndingPosition>134</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P02893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>45444</EpitopeId>
                <ReferenceStartingPosition>126</ReferenceStartingPosition>
                <ReferenceEndingPosition>134</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345517</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345516</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp23</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>DPNANPNVD</LinearSequence>
                        <StartingPosition>122</StartingPosition>
                        <EndingPosition>130</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P02893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>9691</EpitopeId>
                <ReferenceStartingPosition>130</ReferenceStartingPosition>
                <ReferenceEndingPosition>138</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The sequence is also found at residues 122-130 and 138-146 in the circumsporozoite protein.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345519</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345518</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>sh2</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KPAGKGSPS</LinearSequence>
                        <StartingPosition>33</StartingPosition>
                        <EndingPosition>41</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA29733.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>32646</EpitopeId>
                <ReferenceStartingPosition>339</ReferenceStartingPosition>
                <ReferenceEndingPosition>447</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The sequence is from the sporozoite hepatocyte-binding antigen (SHEBA or Pfs16) expressed on sporozoites and gametocytes.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345520</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345521</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>sh3</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SPSTLQTPG</LinearSequence>
                        <StartingPosition>39</StartingPosition>
                        <EndingPosition>47</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA29733.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>60271</EpitopeId>
                <ReferenceStartingPosition>39</ReferenceStartingPosition>
                <ReferenceEndingPosition>47</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The sequence is from the sporozoite hepatocyte-binding antigen (SHEBA or Pfs16) expressed on sporozoites and gametocytes.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345523</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345524</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>sh4</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TPGSSSGAS</LinearSequence>
                        <StartingPosition>45</StartingPosition>
                        <EndingPosition>53</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAA29733.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>65592</EpitopeId>
                <ReferenceStartingPosition>45</ReferenceStartingPosition>
                <ReferenceEndingPosition>53</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The sequence is from the sporozoite hepatocyte-binding antigen (SHEBA or Pfs16) expressed on sporozoites and gametocytes.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345526</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345525</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>sh5</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GPNQGGLSQ</LinearSequence>
                        <StartingPosition>58</StartingPosition>
                        <EndingPosition>66</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P17503.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5843</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>21716</EpitopeId>
                <ReferenceStartingPosition>58</ReferenceStartingPosition>
                <ReferenceEndingPosition>66</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>The sequence is from the sporozoite hepatocyte-binding antigen (SHEBA or Pfs16) expressed on sporozoites and gametocytes.</EpitopeComments>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345527</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345528</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ls1</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IPAIELPSE</LinearSequence>
                        <StartingPosition>1658</StartingPosition>
                        <EndingPosition>1666</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>Q25893</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>27791</EpitopeId>
                <ReferenceStartingPosition>1658</ReferenceStartingPosition>
                <ReferenceEndingPosition>1666</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345529</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345530</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ls3</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IPHQSSLPQ</LinearSequence>
                        <StartingPosition>1673</StartingPosition>
                        <EndingPosition>1681</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>Q25893</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>27863</EpitopeId>
                <ReferenceStartingPosition>1673</ReferenceStartingPosition>
                <ReferenceEndingPosition>1681</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345533</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345534</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ls4</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LPQDNRGNS</LinearSequence>
                        <StartingPosition>1679</StartingPosition>
                        <EndingPosition>1687</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>Q25893</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>38640</EpitopeId>
                <ReferenceStartingPosition>1679</ReferenceStartingPosition>
                <ReferenceEndingPosition>1687</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345536</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345535</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ls5</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KPEQKEDKS</LinearSequence>
                        <StartingPosition>1728</StartingPosition>
                        <EndingPosition>1736</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>Q25893</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>32697</EpitopeId>
                <ReferenceStartingPosition>1728</ReferenceStartingPosition>
                <ReferenceEndingPosition>1736</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345537</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345538</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>ls7</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KPNDKSLYD</LinearSequence>
                        <StartingPosition>1850</StartingPosition>
                        <EndingPosition>1858</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>Q25893</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>32803</EpitopeId>
                <ReferenceStartingPosition>1850</ReferenceStartingPosition>
                <ReferenceEndingPosition>1858</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345539</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345540</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>tr1</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SPCSVTCGK</LinearSequence>
                        <StartingPosition>251</StartingPosition>
                        <EndingPosition>259</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>60005</EpitopeId>
                <ReferenceStartingPosition>251</ReferenceStartingPosition>
                <ReferenceEndingPosition>259</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345542</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345541</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>tr2</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>KPNIPEDSEK</LinearSequence>
                        <StartingPosition>361</StartingPosition>
                        <EndingPosition>370</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>32806</EpitopeId>
                <ReferenceStartingPosition>361</ReferenceStartingPosition>
                <ReferenceEndingPosition>370</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345544</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345545</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>tr3</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IPYSPLPPK</LinearSequence>
                        <StartingPosition>413</StartingPosition>
                        <EndingPosition>421</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>28124</EpitopeId>
                <ReferenceStartingPosition>413</ReferenceStartingPosition>
                <ReferenceEndingPosition>421</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345546</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345547</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>tr4</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EPSPNPEEGK</LinearSequence>
                        <StartingPosition>327</StartingPosition>
                        <EndingPosition>336</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>13769</EpitopeId>
                <ReferenceStartingPosition>327</ReferenceStartingPosition>
                <ReferenceEndingPosition>336</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345548</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345549</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>tr5</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>HPEREEHEK</LinearSequence>
                        <StartingPosition>473</StartingPosition>
                        <EndingPosition>481</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>24444</EpitopeId>
                <ReferenceStartingPosition>473</ReferenceStartingPosition>
                <ReferenceEndingPosition>481</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345550</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345551</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>tr6</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>NPENPPNPDI</LinearSequence>
                        <StartingPosition>348</StartingPosition>
                        <EndingPosition>357</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>45343</EpitopeId>
                <ReferenceStartingPosition>348</ReferenceStartingPosition>
                <ReferenceEndingPosition>357</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345552</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345553</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>tr7</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>VPKNPEDDR</LinearSequence>
                        <StartingPosition>376</StartingPosition>
                        <EndingPosition>384</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>70349</EpitopeId>
                <ReferenceStartingPosition>376</ReferenceStartingPosition>
                <ReferenceEndingPosition>384</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345555</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345554</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>tr8</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>PPKVLDNER</LinearSequence>
                        <StartingPosition>419</StartingPosition>
                        <EndingPosition>427</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>48811</EpitopeId>
                <ReferenceStartingPosition>419</ReferenceStartingPosition>
                <ReferenceEndingPosition>427</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345557</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345556</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>tr9</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>VPNSEDRETR</LinearSequence>
                        <StartingPosition>443</StartingPosition>
                        <EndingPosition>452</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>70401</EpitopeId>
                <ReferenceStartingPosition>443</ReferenceStartingPosition>
                <ReferenceEndingPosition>452</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345559</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345558</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>tr10</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>RPHGRNNENR</LinearSequence>
                        <StartingPosition>452</StartingPosition>
                        <EndingPosition>461</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>55172</EpitopeId>
                <ReferenceStartingPosition>452</ReferenceStartingPosition>
                <ReferenceEndingPosition>461</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345560</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345561</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>tr11</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EPEDDQPRPR</LinearSequence>
                        <StartingPosition>298</StartingPosition>
                        <EndingPosition>307</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>13631</EpitopeId>
                <ReferenceStartingPosition>297</ReferenceStartingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345563</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345562</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>tr12</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LPPKVLDNER</LinearSequence>
                        <StartingPosition>418</StartingPosition>
                        <EndingPosition>427</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>38620</EpitopeId>
                <ReferenceStartingPosition>418</ReferenceStartingPosition>
                <ReferenceEndingPosition>427</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345564</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345565</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>tr13</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IPDSIQDSL</LinearSequence>
                        <StartingPosition>164</StartingPosition>
                        <EndingPosition>172</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>27814</EpitopeId>
                <ReferenceStartingPosition>164</ReferenceStartingPosition>
                <ReferenceEndingPosition>172</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345567</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345566</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>tr14</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IPEDSEKEV</LinearSequence>
                        <StartingPosition>364</StartingPosition>
                        <EndingPosition>372</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>27817</EpitopeId>
                <ReferenceStartingPosition>364</ReferenceStartingPosition>
                <ReferenceEndingPosition>372</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345569</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345568</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>tr18</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IPKKPENKH</LinearSequence>
                        <StartingPosition>390</StartingPosition>
                        <EndingPosition>398</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>27899</EpitopeId>
                <ReferenceStartingPosition>390</ReferenceStartingPosition>
                <ReferenceEndingPosition>398</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345571</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345570</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>tr19</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>TPKHPEREE</LinearSequence>
                        <StartingPosition>470</StartingPosition>
                        <EndingPosition>478</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>65620</EpitopeId>
                <ReferenceStartingPosition>470</ReferenceStartingPosition>
                <ReferenceEndingPosition>478</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345573</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345572</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>tr21</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GPFMKAVCV</LinearSequence>
                        <StartingPosition>228</StartingPosition>
                        <EndingPosition>236</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>21618</EpitopeId>
                <ReferenceStartingPosition>228</ReferenceStartingPosition>
                <ReferenceEndingPosition>236</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345574</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345575</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>tr22</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>PPKWEPLDV</LinearSequence>
                        <StartingPosition>287</StartingPosition>
                        <EndingPosition>295</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P16893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>48812</EpitopeId>
                <ReferenceStartingPosition>287</ReferenceStartingPosition>
                <ReferenceEndingPosition>295</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345577</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5101 (HLA-B51) as assessed using the T2-B53(HLA-B*5301) cell line, which also expresses HLA-B51, in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>40</MhcAlleleId>
                    </MhcBinding>
                </Assays>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Table 2</LocationOfData>
                        <MhcBindingId>1345576</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <AssayComments>The epitope did not bind to HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp24</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ENDIEKKICKMEKCS</LinearSequence>
                        <StartingPosition>376</StartingPosition>
                        <EndingPosition>390</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P02893.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5833</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>13455</EpitopeId>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>1345585</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <GeoLocId>http://purl.obolibrary.org/obo/GAZ_00000907</GeoLocId>
                                <Age>Adults</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Plasmodium falciparum [Mosquito Stage] [sporozoite]</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ENDIEKKICKMEKCS</LinearSequence>
                                            <StartingPosition>376</StartingPosition>
                                            <EndingPosition>390</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P02893.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5833</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Donors were from the Gambian village, Brefet, which has hyperendemic malaria. PBMC were collected at the time of year with lowest malaria transmission.  PBMC were stimulated with a pool of peptides, including the epitope, and each containing the HLA-B*3501-binding motif. IL-2 was added at 72 h. CTL assays were performed on day 8.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>195</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>cp24</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ENDIEKKICKMEKCS</LinearSequence>
                                        <StartingPosition>376</StartingPosition>
                                        <EndingPosition>390</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P02893.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5833</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>8</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTL derived from 8 donors from a malaria-hyperendemic area of Gambia were not stimulated by the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>cp25</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ELDYANDIEKKICKM</LinearSequence>
                        <StartingPosition>357</StartingPosition>
                        <EndingPosition>371</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P19597.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>5843</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>13000</EpitopeId>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <TCell>
                        <LocationOfData>Figure 3</LocationOfData>
                        <TCellId>1345584</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                                <GeoLocId>http://purl.obolibrary.org/obo/GAZ_00000907</GeoLocId>
                                <Age>Adults</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Environmental exposure to endemic/ubiquitous agent without evidence for disease</InVivoProcessType>
                                <DiseaseState>ONTIE:0003423</DiseaseState>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>5843</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Plasmodium falciparum (isolate NF54) [Mosquito Stage] [sporozoite]</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <InVitroAdministration>
                                <ProcessType>Restimulation in vitro</ProcessType>
                                <ResponderCellType>T cell</ResponderCellType>
                                <StimulatorCellType>PBMC</StimulatorCellType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>ELDYANDIEKKICKM</LinearSequence>
                                            <StartingPosition>357</StartingPosition>
                                            <EndingPosition>371</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P19597.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>5843</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </InVitroAdministration>
                            <ImmunizationComments>Donors were from the Gambian village, Brefet, which has hyperendemic malaria. PBMC were collected at the time of year with lowest malaria transmission.  PBMC were stimulated with a pool of peptides, including the epitope, and each containing the HLA-B*3501-binding motif. IL-2 was added at 72 h. CTL assays were performed on day 8.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Blood</CellTissueType>
                            <CellType>T cell</CellType>
                            <CellCultureConditions>Short Term Restimulated</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Lymphoid</CellTissueType>
                            <CellType>B cell</CellType>
                            <CellCultureConditions>Cell Line / Clone (EBV transformed, B-LCL)</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>195</MhcAlleleId>
                            <MhcEvidenceCode>Not determined</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>cp25</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ELDYANDIEKKICKM</LinearSequence>
                                        <StartingPosition>357</StartingPosition>
                                        <EndingPosition>371</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P19597.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>5843</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>67</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>8</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>CTL derived from 8 donors from a malaria-hyperendemic area of Gambia were not stimulated by the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>α3</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YPAEITLTW</LinearSequence>
                        <StartingPosition>233</StartingPosition>
                        <EndingPosition>241</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P30491.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 2</LocationOfData>
                <EpitopeId>75246</EpitopeId>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <MhcBinding>
                        <LocationOfData>Figure 1 and Table 2</LocationOfData>
                        <MhcBindingId>1345588</MhcBindingId>
                        <AssayInformation>
                            <AssayTypeId>285</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope was shown to bind HLA-B*5301 (HLA-B53) as assessed using the T2-B53(HLA-B*5301) cell line in an MHC assembly assay. The epitope was added to lysates of 35S-methionine-labelled T2-B53 cells, and stable assembled class I molecules were precipitated with monoclonal anti-HLA antibodies and separated by one dimensional isoelectric focusing. The epitope was the major self-peptide eluted from HLA-B53.</AssayComments>
                        </AssayInformation>
                        <MhcAlleleId>44</MhcAlleleId>
                    </MhcBinding>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

